View item

US Department of Defense – Peer Reviewed Alzheimer's Research Program (PRARP) – New Investigator Research Award
Sponsor: US Department of Defense 		Closing Date: 27-Sep-2018
The Peer Reviewed Alzheimer's Research Program (PRARP)’s mission is devoted to understanding the association between traumatic brain injury (TBI) and Alzheimer’s disease (AD)/AD-related dementias (ADRD), and reducing the burden on affected individuals and caregivers, especially in the military and Veteran communities. The PRARP’s vision is to address the long-term consequences of TBI as they pertain to AD and ADRD. For FY18, the PRARP is requiring applications to describe the type of dementia that will be the research focus of the application. These are limited to Alzheimer’s dementia, Lewy body dementia, frontotemporal dementia, mixed dementia, and vascular dementia. Chronic traumatic encephalopathy (CTE) research is discouraged.

The intent of the FY18 PRARP New Investigator Research Award is to support early-career investigators interested in novel research efforts or new technologies within TBI and AD/ADRD.

Eligibility
• The Principal Investigator (PI) must be an independent, early-career investigator within 3 years of his/her first independent faculty position (or equivalent).

Key Mechanism Elements
• Applications must address one or more of the following FY18 PRARP Overarching Challenges:
- Paucity of Research Resources
- Paucity of Clinical Studies
- Diagnostic Technologies, Tests, Biomarkers, or Devices
- Epidemiology
- Quality of Life
- Caregiver Support
• Applications should address at least one of the following FY18 PRARP Focus Areas:
- Mechanisms of Pathogenesis
- Biomarkers
- Quality of Life
- Caregiver Support
- Epidemiological Research
- Novel Target Identification
- Non-pharmacological Interventions
• Research considering pharmacologic interventions is specifically discouraged under this mechanism.
• Preliminary data, while not required, are encouraged.

Funding
• Maximum funding of USD $225,000 for direct costs (plus indirect costs).
• Maximum period of performance is 3 years.

Please see the U.S. Department of Defense Congressionally Directed Medical Research Program (CDMRP) website at http://cdmrp.army.mil/funding/prarp and http://cdmrp.army.mil/prarp/default for further information. Pre-applications are submitted via the CDMRP’s Electronic Biomedical Research Application Portal (EBRAP) and full applications are submitted via Grants.gov. For complete instructions for pre-applications and full applications, you must refer to both the Program Announcement and General Application Instructions documents.

Key Dates
Full applications due to UQR&I: 20 September 2018 (new date)
Pre-applications (mandatory) close with US Department of Defense: 27 September 2018 (new date)
Full applications close with US Department of Defense: 11 October 2018 (new date)

Ahead of internal review, ensure all online components on EBRAP or Grants.gov are complete. To initiate review, email your completed Funding Application Coversheet to internationalgrants@research.uq.edu.au. Interested applicants are strongly encouraged to make contact with the UQR&I international team (via internationalgrants@research.uq.edu.au) well in advance of the UQR&I internal deadline to discuss their application.
Website: http://cdmrp.army.mil/funding/prarp

Return